Huayuan Zhu

The First Affiliated Hospital of Nanjing Medical University - Department of Hematology

Nanjing, 210029

China

SCHOLARLY PAPERS

3

DOWNLOADS

162

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Single-Cell RNA-Seq Reveals LGALS1 and LAG3 as Novel Drivers of Ibrutinib Resistance in Chronic Lymphocytic Leukemia

Number of pages: 34 Posted: 09 Sep 2021
Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, Nanjing Medical University - Center for Global Health and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 107 (547,358)

Abstract:

Loading...

Chronic lymphocytic leukemia, Ibrutinib resistance, Single-cell RNA sequencing, Galectin-1 inhibitor

2.

Chidamide-BEAC Plus Autologous Stem Cell Transplantation in High-Risk Non-Hodgkin Lymphoma: A Phase II Clinical Trial

Number of pages: 28 Posted: 27 Jan 2023
Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Anhui Provincial Hospital - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Anhui Provincial Hospital - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 41 (919,518)

Abstract:

Loading...

Chidamide, BEAC, autologous stem cell transplantation, high-risk, non-Hodgkin lymphoma

3.

Single-Cell Transcriptome Analysis Uncovers Heterogeneity and Key Regulators in Ibrutinib-Resistant Chronic Lymphocytic Leukemia

Number of pages: 45 Posted: 12 Nov 2021
The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Center for Global Health, Nanjing Medical University - Center for Global Health and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 14 (1,225,318)

Abstract:

Loading...

chronic lymphocytic leukemia, Ibrutinib resistance, single-cell RNA sequencing, LGALS1, LAG3